AVBP
ArriVent BioPharma, Inc.
13.51
+0.02 (+0.11%)
52w low 11.36
35.83 high
8.8% of range
Financial Analysis
| Ratio | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| Return on Equity | -- | -12.6% | -11.5% | -11.6% | -13.4% | -13.6% | |
| Return on Assets | -- | -11.7% | -10.7% | -10.7% | -12.4% | -12.6% | |
| Return on Inv Capital | -- | -10.6% | -9.9% | -10.0% | -11.2% | -11.3% | |
| Liquidity | |||||||
| Current Ratio | -- | 12.74x | 14.90x | 12.83x | 13.95x | 14.16x | |
| Quick Ratio | -- | 12.74x | 14.90x | 12.83x | 13.95x | 14.16x | |
| Cash Ratio | -- | 5.74x | 5.23x | 1.76x | 2.48x | 5.56x | |
| Leverage | |||||||
| Debt / Equity | -- | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | |
| Equity Multiplier | -- | 1.08x | 1.07x | 1.08x | 1.08x | 1.08x | |
| Efficiency | |||||||
| Asset Turnover | -- | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | |
| Op CF / Net Income | -- | 0.83x | 1.02x | 0.86x | 0.97x | 0.79x | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--